EnBio Holdings, Inc. (6092) AI Stock Analysis

• Market Cap: ¥5.16B
• Dividend Yield: 1.42%
• Average Volume (3M): 94.46K
• Price to Earnings (P/E): 11.3
• Beta (1Y): 0.68
• Revenue Growth: 11.41%
• EPS Growth: -37.25%
• Country: JP
• Employees: 104
• Sector: Industrials
• Sector Strength: 84
• Industry: Specialty Business Services
• EPS (TTM): -13.91
• Shares Outstanding: 8,175,200
• 10 Day Avg. Volume: 19,180
• 30 Day Avg. Volume: 94,456
• PEG Ratio: 0.26
• Price to Book (P/B): 0.74
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 6.12
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 68 Neutral
• Price Target: ¥747.00 ▲(20.87%Upside)

The overall stock score for EnBio Holdings, Inc. is driven primarily by strong financial performance, particularly in revenue growth and operational efficiency. Technical analysis suggests positive market momentum, though caution is warranted due to overbought signals. The valuation is attractive, offering a reasonable P/E ratio and a modest dividend yield.

EnBio Holdings, Inc. Business Overview & Revenue Model

Company Description

EnBio Holdings, Inc. (6092) is a Japan-based company primarily engaged in the environmental business sector. The company focuses on providing a range of environmental solutions, including soil and groundwater decontamination services. EnBio Holdings leverages advanced technologies to address environmental challenges, contributing to sustainability and ecological preservation.

How the Company Makes Money

EnBio Holdings, Inc. generates revenue primarily through its environmental service offerings, particularly in soil and groundwater remediation. The company charges fees for its specialized decontamination services, which are essential for construction projects, industrial sites, and areas requiring environmental rehabilitation. Furthermore, EnBio Holdings may form strategic partnerships with government bodies and private sector enterprises seeking sustainable environmental solutions, thereby enhancing its revenue streams. The company's earnings are influenced by regulatory requirements, technological advancements, and the growing emphasis on environmental sustainability.

EnBio Holdings, Inc. Financial Statement Overview

Summary

EnBio Holdings, Inc. shows strong revenue growth and operational efficiency with healthy EBIT and EBITDA margins. However, the decline in net income and challenges in cash flow management, particularly negative free cash flow, could pose risks.

Income Statement

EnBio Holdings, Inc. shows a robust performance with strong revenue growth of 11.44% from 2024 to 2025, indicating positive business momentum. The gross profit margin stands at 24.87% and the net profit margin at 4.24% for 2025, which are moderate but consistent over the years. However, the decline in net income from 2024 to 2025 suggests some pressure on profitability. The EBIT and EBITDA margins are healthy at 7.95% and 12.58%, respectively, reflecting efficient operational management.

Balance Sheet

The balance sheet of EnBio Holdings, Inc. reveals a solid equity base with a debt-to-equity ratio of 1.10, indicating a balanced capital structure. The return on equity (ROE) is relatively low at 4.95% for 2025, showing room for improvement in generating returns for shareholders. The equity ratio is 43.14%, suggesting a stable financial position with a reasonable level of leverage.

Cash Flow

The cash flow statement indicates challenges with free cash flow, which turned negative in 2025, driven by high capital expenditures. The operating cash flow to net income ratio is low at 0.05, highlighting potential inefficiencies in cash generation relative to net income. However, the company has maintained positive operating cash flow, which is a positive indicator of ongoing operational health.

Breakdown
TTM	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement		Total Revenue
10.78B	10.67B	9.58B	8.12B	8.99B	6.84B
	Gross Profit
2.92B	2.65B	2.48B	2.76B	2.43B	1.89B
	EBIT
1.18B	847.76M	815.15M	1.36B	1.23B	617.90M
	EBITDA
1.62B	1.34B	1.62B	1.76B	1.57B	981.00M
	Net Income Common Stockholders
929.29M	452.69M	708.76M	812.06M	654.05M	304.06M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
3.38B	3.29B	3.60B	2.83B	2.37B	2.02B
	Total Assets
20.84B	21.20B	19.31B	17.35B	16.37B	15.70B
	Total Debt
9.97B	10.10B	8.62B	8.90B	8.58B	9.04B
	Net Debt
6.59B	6.81B	5.02B	6.07B	6.21B	7.02B
	Total Liabilities
11.86B	11.96B	10.72B	10.49B	10.40B	10.38B
	Stockholders Equity
8.89B	9.14B	8.49B	6.79B	5.89B	5.29B
Cash Flow		Free Cash Flow
0.00	-1.44B	584.36M	824.13M	1.25B	-1.43B
	Operating Cash Flow
0.00	21.92M	1.66B	1.99B	2.41B	297.16M
	Investing Cash Flow
0.00	-1.60B	-1.58B	-1.77B	-1.48B	-2.16B
	Financing Cash Flow
0.00	1.27B	638.92M	240.73M	-534.92M	928.54M

EnBio Holdings, Inc. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 618.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6092, the sentiment is Positive. The current price of 618 is below the 20-day moving average (MA) of 624.05, above the 50-day MA of 592.82, and above the 200-day MA of 591.67, indicating a bullish trend. The MACD of 10.06 indicates Negative momentum. The RSI at 61.19 is Neutral, neither overbought nor oversold. The STOCH value of 82.29 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:6092.

EnBio Holdings, Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
7850	74 Outperform	¥2.64B	5.76		2.27%	1.84%	75.79%
7883	70 Outperform	¥5.41B	16.28		0.57%	-1.18%	29.19%
7812	70 Neutral	¥5.09B	5.01		4.60%	-0.27%	36.59%
6092	68 Neutral	¥5.16B	11.32		1.42%	11.41%	-37.25%
Sector *	66 Neutral	$4.44B	12.08	5.34%	5.82%	4.17%	-11.81%
3948	65 Neutral	¥6.61B	62.72		3.48%	-15.74%	-80.43%
7916	64 Neutral	¥4.03B	57.17		3.80%	0.38%	24.47%

EnBio Holdings, Inc. Corporate Events

EnBio Holdings Reports Fiscal Year 2025 Financial Results with Revenue Growth Amid Profit Decline

EnBio Holdings, Inc. reported its consolidated financial results for the fiscal year ended March 31, 2025, showing an increase in net sales by 11.4% to ¥10,668 million. However, the company experienced a decline in ordinary profit and profit attributable to owners of the parent by 34.2% and 36.1%, respectively. The financial results reflect challenges in maintaining profitability despite revenue growth. The inclusion of two new companies, DEFNE ENERGY INVESTMENT INDUSTRY TRADE LIMITED and EnBio C West, G.K., in its consolidation scope indicates strategic expansion efforts. The forecast for the next fiscal year predicts further growth in net sales and profits, suggesting a positive outlook for the company’s future performance.